Found 7 matching trials
A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo PHASE2 The purpose of this study is to determine the efficacy of the topical antib...
Show More Location
Dr. Robert Reid Cabral Children Hospital
Learn More & Join Trial
LTX-109 as Treatment for Hidradenitis Suppurativa PHASE1 An Open label Phase II//proof of concept-study to demonstrate if percutaneo...
Show More Location
University Hospital of North Norway
Learn More & Join Trial
Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection. PHASE2 A Phase IIa, double-blind, placebo-controlled, randomised study designed to...
Show More Location
ClinSmart Sweden AB
Learn More & Join Trial
A Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of Topical LTX-109 in Subjects Nasally Colonized With Methicillin-resistant/-Sensitive Staphylococcus Aureus (MRSA/MSSA) PHASE1 This is a pilot study conducted to evaluate the safety, local tolerability ...
Show More Location
Skåne University Hospital
Learn More & Join Trial
Study to Evaluate the Efficacy, Safety and Tolerability of 3% LTX-109 for Nasal Decolonisation of Staphylococcus Aureus PHASE2 A Phase IIa, double-blind, placebo-controlled, randomised study designed to...
Show More Location
ClinSmart Sweden AB
Learn More & Join Trial
A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection PHASE2 The purpose of this study is to evaluate the safety and tolerability of Lyt...
Show More Location
Debreceni Egyetem Orvos-és Egészségtudományi
Learn More & Join Trial
A Study to Evaluate the Safety and Efficacy of 3% LTX-109 for Nasal Decolonisation of Staphylococcus PHASE1 A Phase I/IIa, double-blind, placebo-controlled, randomised study designed ...
Show More Location
ClinSmart Sweden AB
Learn More & Join Trial